L.M. Kohn & Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$265K Sell
2,640
-126
-5% -$11.3K 0.32% 92
2025
Q2
$229K Buy
2,766
+94
+4% +$7.5K 0.06% 243
2025
Q1
$217K Buy
2,672
+100
+4% +$8.94K 0.06% 253
2024
Q4
$232K Buy
2,572
+25
+1% +$2.42K 0.06% 229
2024
Q3
$252K Hold
2,547
0.06% 230
2024
Q2
$236K Sell
2,547
-131
-5% -$11.7K 0.06% 233
2024
Q1
$254K Hold
2,678
0.07% 218
2023
Q4
$239K Sell
2,678
-71
-3% -$5.27K 0.08% 203
2023
Q3
$201K Sell
2,749
-28
-1% -$2.24K 0.07% 212
2023
Q2
$231K Hold
2,777
0.09% 196
2023
Q1
$212K Sell
2,777
-242
-8% -$20.1K 0.09% 195
2022
Q4
$251K Sell
3,019
-310
-9% -$25.1K 0.12% 178
2022
Q3
$265K Sell
3,329
-275
-8% -$23.2K 0.13% 162
2022
Q2
$268K Buy
3,604
+234
+7% +$17.6K 0.13% 179
2022
Q1
$303K Buy
+3,370
New +$311K 0.12% 185

Other funds holding XBI